If you’re anything like the average American, you’re consuming way too much sodium. You may have tried to kick the habit, but found that you just don’t like the taste of low sodium foods as much.
A recent study published in the journal Appetite may help. Researchers split about 150 participants into three groups to test how much they liked three soups over repeated tastings: a standard tomato soup, a low sodium
tomato soup, and a low sodium tomato soup seasoned with herbs and spices.
On the first day of the study, everyone tasted samples — about two tablespoons each — of all three soups. For the next three days, participants ate larger portions of their one assigned soup. On the last day, all three groups again sampled small portions of the three soups. Participants rated how much they liked each soup every day.
Results from the study suggest three strategies that can help you cut back on sodium without sacrificing flavor:
- Find the blend that you like best. Before beginning the study, researchers tested three different herb and spice blends to add to the low sodium soup: blends were based around basil, cumin and coriander, or oregano. No one blend was a clear favorite among participants overall, but individual participants had definite preferences. The lesson is to find the herb and spice blend that you prefer.
There’s strong research now showing that being active can reduce your risk of colorectal cancer, but how physical activity affects survivors of this cancer is not as clear. Now comes a study suggesting that being active — both before and after diagnosis —can lengthen survival for colorectal cancer survivors.
Not watching a lot of television — a common measure for sedentary living — was also found to improve survival. Survivors who were watching fewer than two hours a day of TV before diagnosis had a reduced risk of mortality compared to those watching five or more hours of TV a day.
The study was published in the Journal of Clinical Oncology last week.
For pre-diagnosis, study authors used data from approximately 3,800 survivors who were part of the large NIH-AARP Diet and Health Study study. In the mid 1990s, the participants were 50 to 71 years old. They answered questionnaires about how much TV they watched, their activity and other lifestyle habits. Those who had developed colorectal cancer were identified in 2006. Continue reading
A new long-term study that adds to the research on diet and breast cancer survival finds that women with certain types of breast tumors who reduced their dietary fat for years after diagnosis — and also lost weight — had lower death rates over the next 15 years than survivors on a standard diet.
The study was presented today at the San Antonio Breast Cancer Symposium and is not yet published in a journal.
It was funded in part by AICR and joins a growing body of research investigating how diet affects women diagnosed with breast cancer. In October, an AICR report on breast cancer survivorship in partnership with WCRF found some indication that fat may play a role in survival. The Continuous Update Project report found there was limited but consistent research suggesting that eating lower amounts of total fat and in particular, saturated fat, before a diagnosis of breast cancer linked to improved survival.
Weight loss may also play a role, as the low-fat group lost a a modest but significant amount of weight in this study. The CUP report found indications that being a healthy weight may lengthen survival for women diagnosed with breast cancer. But the report’s findings were not strong enough to make a specific recommendation.
Observational evidence relating to low-fat diets and breast cancer survival is mixed and previous research from another major randomized dietary study among breast cancer survivors – the WHEL study – found a lowfat diet did not affect mortality or recurrence.
The study presented today included approximately 2,400 women who were part of Women’s Intervention Nutrition Study (WINS), a study that first launched in 1987. All the women were diagnosed with early stage breast cancer and they joined the study within six months of diagnosis. Continue reading